Abstract
Neurological complications are increasingly recognized with SARS-CoV-2, the causative pathogen for COVID-19. We present a single-center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African-American women with laboratory-confirmed SARS-CoV-2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID-19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1240-1244 |
| Number of pages | 5 |
| Journal | Annals of Clinical and Translational Neurology |
| Volume | 7 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 1 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'De Novo Status Epilepticus in patients with COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS